Evidence map›Paper›PMID 23267071›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Two methods for full-length RNA sequencing for low quantities of cells and single cells.

Xinghua Pan, Russell E Durrett, Haiying Zhu, Yoshiaki Tanaka, Yumei Li, Xiaoyuan Zi, Sadie L Marjani, Ghia Euskirchen, Chao Ma, Robert H Lamotte and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Biosynthesis of Camphane Volatile Terpenes inPlants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Geostatistical visualization of ecological interactions in tumors.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2019
    Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Xinghua PanDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA. xinghua.pan@yale.edu
Russell E Durrett
Haiying Zhu
Yoshiaki Tanaka
Yumei Li
Xiaoyuan Zi
Sadie L Marjani
Ghia Euskirchen
Chao Ma
Robert H Lamotte
In-Hyun Park
Michael P Snyder
Christopher E Mason
Sherman M Weissman
Yale University · USCornell University · USPalo Alto University · USJiangsu University · CNSecond Military Medical University · CN

Funding

Project 3: Effect of Age and Longevity Genes on Epigenomic MechanismsP01GM099130 · NIGMS · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2011 to 2015
$11.4M
Peripheral Neural Mechanisms of Inflammatory Itch and PainR01NS014624 · NINDS · YALE UNIVERSITY · PI LA MOTTE, ROBERT H · 1985 to 2016
$7.2M
Epigenome Interactions in Complex Neurogenetic DisordersR01NS076465 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MASON, CHRISTOPHER EDWARD, ROSS, MARGARET ELIZABETH · 2011 to 2015
$5.8M
Transcriptome & Methylome Analysis of Single CellsR21HD066457 · NICHD · YALE UNIVERSITY · PI WEISSMAN, SHERMAN MORTON · 2010 to 2011
$447k
Analyzing allele specific gene expression and regulation in C. albicans.F32GM087109 · NIGMS · YALE UNIVERSITY · PI MARJANI, SADIE LYNNE · 2009 to 2010
$102k
NICHD NIH HHS 1R21HD066457-01NICHD NIH HHS R21 HD066457NIGMS NIH HHS 1P01GM099130-01NIGMS NIH HHS F32 GM087109NIGMS NIH HHS F32GM087109NIGMS NIH HHS P01 GM099130NINDS NIH HHS 1R01NS076465-01NINDS NIH HHS 1R01NS076465-02NINDS NIH HHS R01 NS014624NINDS NIH HHS R01 NS076465
6 · The paper itself

Abstract

The ability to determine the gene expression pattern in low quantities of cells or single cells is important for resolving a variety of problems in many biological disciplines. A robust description of the expression signature of a single cell requires determination of the full-length sequence of the expressed mRNAs in the cell, yet existing methods have either 3' biased or variable transcript representation. Here, we report our protocols for the amplification and high-throughput sequencing of very small amounts of RNA for sequencing using procedures of either semirandom primed PCR or phi29 DNA polymerase-based DNA amplification, for the cDNA generated with oligo-dT and/or random oligonucleotide primers. Unlike existing methods, these protocols produce relatively uniformly distributed sequences covering the full length of almost all transcripts independent of their sizes, from 1,000 to 10 cells, and even with single cells. Both protocols produced satisfactory detection/coverage of the abundant mRNAs from a single K562 erythroleukemic cell or a single dorsal root ganglion neuron. The phi29-based method produces long products with less noise, uses an isothermal reaction, and is simple to practice. The semirandom primed PCR procedure is more sensitive and reproducible at low transcript levels or with low quantities of cells. These methods provide tools for mRNA sequencing or RNA sequencing when only low quantities of cells, a single cell, or even degraded RNA are available for profiling.

Indexed as

DNA PrimersGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansK562 CellsNucleic Acid Amplification TechniquesPolymerase Chain ReactionRNA, MessengerSingle-Cell AnalysisDNA PrimersRNA, Messenger

Identifiers

PMID23267071
PMCPMC3545756
OpenAlexW2050794663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.